Sumitomo Mitsui Trust Holdings, Inc. Cerus Corp Transaction History

Sumitomo Mitsui Trust Holdings, Inc.

$156 Billion
Q2 2025

A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Cerus Corp stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 6,069,837 shares of CERS stock, worth $7.83 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

6,069,837

Previous 6,190,889 1.96%

Holding current value

$7.83 Million

Previous $8.61 Million 0.55%

% of portfolio

0.01%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 31, 2025	SELL	$1.22 - $1.51 $147,683 - $182,788	-121,052 Reduced 1.96%	6,069,837 $8.56 Million
Q1 2025 Apr 25, 2025	SELL	$1.39 - $2.15 $376,405 - $582,209	-270,795 Reduced 4.19%	6,190,889 $8.61 Million
Q4 2024 Jan 28, 2025	SELL	$1.52 - $2.03 $879,476 - $1.17 Million	-578,603 Reduced 8.22%	6,461,684 $9.95 Million
Q3 2024 Nov 05, 2024	SELL	$1.7 - $2.39 $778,520 - $1.09 Million	-457,953 Reduced 6.11%	7,040,287 $12.3 Million
Q2 2024 Jul 19, 2024	SELL	$1.62 - $2.04 $408,985 - $515,018	-252,460 Reduced 3.26%	7,498,240 $13.2 Million
Q1 2024 Apr 19, 2024	BUY	$1.66 - $2.42 $303,164 - $441,962	182,629 Added 2.41%	7,750,700 $14.6 Million
Q4 2023 Jan 30, 2024	SELL	$1.25 - $2.35 $430,838 - $809,976	-344,671 Reduced 4.36%	7,568,071 $16.3 Million
Q3 2023 Oct 30, 2023	SELL	$1.5 - $3.07 $485,623 - $993,909	-323,749 Reduced 3.93%	7,912,742 $12.8 Million
Q2 2023 Jul 31, 2023	BUY	$1.79 - $2.9 $392,298 - $635,566	219,161 Added 2.73%	8,236,491 $20.3 Million
Q1 2023 Apr 27, 2023	BUY	$2.65 - $3.81 $2.24 Million - $3.22 Million	846,050 Added 11.8%	8,017,330 $23.8 Million
Q4 2022 Jan 30, 2023	SELL	$3.38 - $4.22 $543,297 - $678,318	-160,739 Reduced 2.19%	7,171,280 $26.2 Million
Q3 2022 Oct 21, 2022	SELL	$3.43 - $5.83 $10.1 Million - $17.2 Million	-2,955,332 Reduced 28.73%	7,332,019 $26.4 Million
Q2 2022 Jul 26, 2022	SELL	$4.41 - $5.69 $1.54 Million - $1.99 Million	-349,955 Reduced 3.29%	10,287,351 $54.4 Million
Q1 2022 Apr 27, 2022	SELL	$4.81 - $6.99 $4.29 Million - $6.24 Million	-892,410 Reduced 7.74%	10,637,306 $58.4 Million
Q4 2021 Feb 02, 2022	SELL	$5.97 - $7.93 $4.54 Million - $6.03 Million	-760,820 Reduced 6.19%	11,529,716 $78.5 Million
Q3 2021 Oct 25, 2021	SELL	$4.79 - $6.68 $4.12 Million - $5.75 Million	-860,572 Reduced 6.54%	12,290,536 $74.8 Million
Q2 2021 Aug 02, 2021	SELL	$5.35 - $6.35 $695,906 - $825,982	-130,076 Reduced 0.98%	13,151,108 $77.7 Million
Q1 2021 Apr 30, 2021	BUY	$5.68 - $7.87 $12.4 Million - $17.1 Million	2,177,974 Added 19.62%	13,281,184 $79.8 Million
Q4 2020 Feb 05, 2021	BUY	$5.25 - $8.56 $7.53 Million - $12.3 Million	1,434,508 Added 14.84%	11,103,210 $76.8 Million
Q3 2020 Oct 30, 2020	SELL	$5.78 - $7.47 $6.12 Million - $7.9 Million	-1,058,184 Reduced 9.86%	9,668,702 $60.5 Million
Q2 2020 Jul 27, 2020	BUY	$4.5 - $7.02 $726,259 - $1.13 Million	161,391 Added 1.53%	10,726,886 $70.8 Million
Q1 2020 Apr 27, 2020	BUY	$2.87 - $5.49 $2.3 Million - $4.39 Million	800,441 Added 8.2%	10,565,495 $49.1 Million
Q4 2019 Jan 31, 2020	BUY	$3.84 - $4.86 $4.69 Million - $5.93 Million	1,220,778 Added 14.29%	9,765,054 $41.2 Million
Q3 2019 Oct 31, 2019	BUY	$4.86 - $6.05 $17 Million - $21.1 Million	3,494,891 Added 69.21%	8,544,276 $44 Million
Q2 2019 Jul 29, 2019	BUY	$4.51 - $6.6 $18.6 Million - $27.2 Million	4,121,845 Added 444.38%	5,049,385 $28.4 Million
Q1 2019 May 08, 2019	BUY	$5.16 - $6.85 $4.79 Million - $6.35 Million	927,540 New	927,540 $5.78 Million

Others Institutions Holding CERS

# of Institutions

165

Shares Held

139M

Call Options Held

100K

Put Options Held

16K

View Full List

About CERUS CORP

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $228M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

More about CERS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.

Account

Sumitomo Mitsui Trust Holdings, Inc. Cerus Corp Transaction History